Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Stockholders Equity

v3.24.2.u1
Condensed Statements of Changes of Stockholders Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balances, Beginning at Dec. 31, 2022 $ 1,833 $ 63,497,868 $ (56,173,207)   $ 7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   161,697     161,697
Net loss     (1,516,864)   (1,516,864)
Balances, Ending at Mar. 31, 2023 $ 1,833 63,659,565 (57,690,071)   5,971,327
Balances, Ending (in shares) at Mar. 31, 2023 18,330,390        
Balances, Beginning at Dec. 31, 2022 $ 1,833 63,497,868 (56,173,207)   7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (2,957,768)
Balances, Ending at Jun. 30, 2023 $ 1,861 64,113,437 (59,130,975) $ (292,236) 4,692,087
Balances, Ending (in shares) at Jun. 30, 2023 18,608,455        
Balances, Beginning at Dec. 31, 2022 $ 1,833 63,497,868 (56,173,207)   7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 18,330,390        
Balances, Ending at Dec. 31, 2023 $ 1,926 65,573,300 (61,469,222) (299,110) 3,806,894
Balances, Ending (in shares) at Dec. 31, 2023 19,257,937        
Balances, Beginning at Mar. 31, 2023 $ 1,833 63,659,565 (57,690,071)   5,971,327
Balances, Beginning (in shares) at Mar. 31, 2023 18,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants $ 47 292,208     292,255
Exercise of warrants (in shares) 467,625        
Shares surrendered in cashless warrant exercises $ (19)     (292,236) (292,255)
Shares surrendered in cashless warrant exercises (in shares) (189,560)        
Share-based compensation expense   161,664     161,664
Net loss     (1,440,904)   (1,440,904)
Balances, Ending at Jun. 30, 2023 $ 1,861 64,113,437 (59,130,975) (292,236) 4,692,087
Balances, Ending (in shares) at Jun. 30, 2023 18,608,455        
Balances, Beginning at Dec. 31, 2023 $ 1,926 65,573,300 (61,469,222) (299,110) 3,806,894
Balances, Beginning (in shares) at Dec. 31, 2023 19,257,937        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   138,969     138,969
Net loss     (1,291,335)   (1,291,335)
Balances, Ending at Mar. 31, 2024 $ 1,926 65,712,269 (62,760,557) (299,110) 2,654,528
Balances, Ending (in shares) at Mar. 31, 2024 19,257,937        
Balances, Beginning at Dec. 31, 2023 $ 1,926 65,573,300 (61,469,222) (299,110) 3,806,894
Balances, Beginning (in shares) at Dec. 31, 2023 19,257,937        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (2,341,168)
Balances, Ending at Jun. 30, 2024 $ 2,776 67,242,537 (63,810,390) (299,110) 3,135,813
Balances, Ending (in shares) at Jun. 30, 2024 27,757,937        
Balances, Beginning at Mar. 31, 2024 $ 1,926 65,712,269 (62,760,557) (299,110) 2,654,528
Balances, Beginning (in shares) at Mar. 31, 2024 19,257,937        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from public offering of common stock, net of offering costs $ 850 1,381,320     1,382,170
Proceeds from public offering of common stock, net of offering costs (shares) 8,500,000        
Share-based compensation expense   148,948     148,948
Net loss     (1,049,833)   (1,049,833)
Balances, Ending at Jun. 30, 2024 $ 2,776 $ 67,242,537 $ (63,810,390) $ (299,110) $ 3,135,813
Balances, Ending (in shares) at Jun. 30, 2024 27,757,937